Cannpal Animal Therapeutics is privately held. The company is headquartered in Australia
Alternatives.pe tracks Cannpal Animal Therapeutics's financials, valuation trends, ownership structure and transaction activity over time.
Last Updated: 2026-07-21
Explore the latest updates and insights
On 13 April 2026, Argent BioPharma Ltd (ASX: RGT), a Perth-based biopharmaceutical company ... see ... see summary
On March 10, 2023, Layton Mills and Margaret Curtis acquired a 52% stake in CannPal Animal ... see ... see summary
AusCann Group Holdings Ltd entered into a Scheme Implementation Deed to acquire CannPal Animal ... ... see summary
AusCann Group Holdings Ltd acquired CannPal Animal Therapeutics Limited from Merchant Opportunities Fund in 2021.